Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes

Ilja L. Kruglikov,Philipp E. Scherer
DOI: https://doi.org/10.1371/journal.ppat.1009306
IF: 7.464
2021-02-18
PLoS Pathogens
Abstract:To optimize prevention and control of the Coronavirus Disease 2019 (COVID-19), we need to understand why just a small number of infected individuals develop severe forms of COVID-19. Whereas comorbidities such as obesity, type 2 diabetes (T2D), cardiovascular diseases (CVDs), old age of patients, and their ethnicity are recognized as important contributors toward worse disease outcome [<a class="ref-tip" href="#ppat.1009306.ref001">1</a>,<a class="ref-tip" href="#ppat.1009306.ref002">2</a>], it is still a matter of discussion what the common critical factors are that directly interact with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
microbiology,virology,parasitology
What problem does this paper attempt to address?